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Studies focused on the pathological–radiological correlation of human Mycoplasma
(M) pneumoniae pneumonia have rarely been reported. Therefore, we extensively
reviewed the literature regarding pathological and radiological studies of Mycoplasma
pneumonia, and compared findings between open lung biopsy specimen and computed
tomography (CT). Major three correlations were summarized. (1) Peribronchial and
perivascular cuffing characterized by mononuclear cells infiltration was correlated with
bronchovascular bundles thickening on CT, which was the most common finding
of this pneumonia. (2) Cellular bronchitis in the small airways accompanied with
exudates or granulation tissue in the lumen revealed as centrilobular nodules on CT. (3)
Neutrophils and exudates in the alveolar lumen radiologically demonstrated as air-space
consolidation or ground-glass opacities. In M. pulmonis-infected mice model, pathologic
patterns are strikingly different according to host cell-mediated immunity (CMI) levels;
treatment with interleukin-2 lead to marked cellular bronchitis in the small airways and
treatment with prednisolone or cyclosporin-A lead to neutrophils and exudates in the
alveolar lumen. Patients with centrilobular nodules predominant radiologic pattern have
a high level of CMI, measuring by tuberculin skin test. From these findings, up-regulation
of host CMI could change radiological pattern to centrilobular nodules predominant,
on the other hand down-regulation of host CMI would change radiological pattern to
ground-glass opacity and consolidation. It was suggested the pathological features of
M. pneumoniae pneumonia may be altered by the level of host CMI.
Keywords: radiological–pathological correlation, open lung biopsy, CT scan, centrilobular nodes,
bronchovascular bundles thickening, host cell-mediated immunity
INTRODUCTION
The majority of Mycoplasma (M) pneumoniae respiratory infection are self-limited. An estimated
3–13% of infected persons with infection experience pneumonia, and the remains are manifested
as upper respiratory tract infection [Clyde, 1993; Waites and Talkington, 2004; Walter et al., 2008;
Centers for Disease Control and Prevention (CDC), 2013]. Therefore pathological specimens
of human M. pneumoniae pneumonia are rarely obtained. Pathological descriptions of this
pneumonia include marked plasma cell-rich lymphocytic infiltration in peribronchial and
perivascular areas, with accumulations of macrophages, neutrophils, and lymphocytes in the
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alveolar spaces, foci of interstitial pneumonia, and hyperplasia
of type II pneumocytes (Golden, 1944; Forsyth and Chanock,
1966; Meyers and Hirschman, 1972; Chan et al., 1999).
Bronchiolitis and alveolitis with dense mononuclear cells
infiltration, epithelioid cell granulation tissue filling alveolar
ducts, organizing alveolar exudates, and hyaline membranes are
characteristic findings in fulminant M. pneumoniae pneumonia
(Koletsky and Weinstein, 1980; Rollins et al., 1986; Ito et al.,
1995; Ebnother et al., 2001; Izumikawa et al., 2014). On
the other hand, the patterns of M. pneumoniae pneumonia
on chest radiography are non-specific segmental or lobar
consolidation, bilateral diffuse reticular interstitial infiltrates
(Putman et al., 1975). Computed tomography (CT) findings of
this pneumonia are bronchovascular thickening, centrilobular
nodules, ground-glass attenuation, or air-space consolidation
(Tanaka et al., 1985; Tanaka N. et al., 1996; Reittner et al.,
2000; Miyashita et al., 2009, 2014). However, there has been
little report radiological–pathological correlation in human
M. pneumoniae pneumonia (Heitzman, 1993). This review
focuses on radiological–pathological correlation of Mycoplasma
pneumonia in mice and humans, and the changes of pulmonary
involvement patterns reflecting by host cell-mediated immunity
(CMI) levels.
RADIOLOGICAL–PATHOLOGICAL
CORRELATION IN ANIMAL MODELS
The pathogenesis of Mycoplasma infection has been studied
in animal model. The pathological changes and patterns are
similar to that seen in experimental infection in hamsters or
mice. In Figures 1A,B, M. pulmonis inoculated mice model
reveals that pathological changes consist with (1) peribronchial
and perivascular mononuclear cells accumulation throughout
large to small airways, (2) cellular bronchiolitis with lumen
exudates and mononuclear cell in airway walls extending into
adjacent alveoli (Tanaka et al., 1996a). Next, inflated lung
specimens of M. pulmonis inoculated mice were prepared
by Heitzman’s (1993) method (Markarian and Dailey, 1993).
Radiological findings of the infected lungs disclosed thickening
of bronchovascular bundles, centrilobular nodules, and ground-
glass opacities (Figures 1C,D). Pathological changes clearly
reflect to radiological findings in M. pulmonis inoculated
mice.
IMMUNOMODULATORS CHANGE THE
PATHOLOGICAL PATTERN OF
Mycoplasma PNEUMONIA
The role of T cells in the pathogenesis of M. pneumoniae
infection can be defined by the apparent correlation of delayed-
type hypersensitivity (DTH) skin reaction to M. pneumoniae
in humans with the severity of disease (Mizutani et al.,
1971). To elucidate immune-pathological mechanism of
Mycoplasma pneumonia, the therapeutic effects of interleukin-2
(IL-2), cyclosporine A (CYA), and prednisolone (PSL) on
mice model (Tanaka et al., 1996a). Mice were intra-nasally
inoculated with M. pulmonis and were treated with IL-2,
FIGURE 1 | Mycoplasma pulmonis infected mice, 2 weeks after inoculation. Low-magnification photomicrographs of non-infected lung (A) and infected lung
(B; HE x17). (C) Radiograph of inflated lung of infected mice reveals bronchovascular bundles thickening, nodules, and ground-glass attenuation. (D) Radiograph of
thin-sliced lung of infected mice shows nodules with centrilobular distribution and consolidation. Reproduced with permission from Tanaka (2016).
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CYA, and PSL every day between Days 3 and 9, and were
killed at Day 14. IL-2 is immunomodulator, especially up-
regulate CMI, and CYA is immunosuppressant, especially
down-regulate CMI of the host. PSL is a more powerful
immunosuppressant. CMI level of the host was assessed by
skin test by sheep red blood cell (SRBC). Peribronchial and
perivascular mononuclear cell cuffing and accumulation of
macrophages at the end of bronchiole were exacerbated in
FIGURE 2 | Low-magnification photomicrographs of lung, 2 weeks after M. pulmonis inoculation (HE x17). (A) Mice without treatment. (B) Mice treated
with interleukin-2, showing marked peribronchial and perivascular lymphocyte cuffing, and no intra-alveolar inflammation. (C) Mice treated with PSL, disclosing
predominance of intra-alveolar inflammatory cell infiltration, and a little peribronchial and perivascular lymphocyte cuffing. Reproduced with permission from Tanaka
and Tamura (1989).
FIGURE 3 | Pathological observation of lung from M. pulmonis infected mice (HE x170). (A) Mice without treatment. (B) Mice treated with interleukin-2,
showing marked peribronchial lymphocyte cuffing and macrophage accumulation at the end bronchiole. (C) Mice treated with PSL, disclosing predominant
intra-alveolar inflammatory cell Infiltration and faint perivascular lymphocyte cuffing. Reproduced with permission from Tanaka and Tamura (1989).
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IL-2 treated mice (Figures 2 and 3). On the other hand,
prominent intra-alveolar inflammatory cell infiltration and
faint peribronchial and perivascular mononuclear cell cuffing
were observed on CYA or PSL treated mice (Figures 2 and
3). CMI to SRBC was increased in IL-2 treated mice, however,
decreased in CYA or PSL treated mice. Another M. pneumoniae
inoculated mice model exhibited host-dependent infection-
related airway obstruction and airway hyperresponsiveness
associated with chemokine and T-helper type 1 pulmonary host
response and not T-helper type 2 response after M. pneumoniae
infection (Fonseca-Aten et al., 2005). Recently, the severity
of the M. pneumoniae pneumonia seemed to depend on the
host innate immunity to the M. pneumoniae, which might be
accelerated by antecedent M. pneumoniae exposure (re-exposure
or latent respiratory infection) through up-regulation of Toll-
like receptor 2 expression on bronchial epithelial cells and
alveolar macrophages using mice model (Saraya et al., 2011,
2014).
FIGURE 4 | Mycoplasma pneumoniae pneumonia in human. (A) Chest x-ray shows infiltrates in the right lower lobe. (B) Consolidation (∗) and bronchovascular
bundles thickening (↑) on CT scan. Reproduced with permission from Tanaka and Hayashi (2007).
FIGURE 5 | Photomicrograph of open lung biopsy specimens in recovery phase of patients with M. pneumoniae pneumonia. Low-magnification views of
small airways show cellular bronchiolitis and exudate in the lumen (A,B). High-magnification of alveolar area disclose stuffed alveoli with exudate, fibrin, neutrophil,
and granulation tissue in alveolar duct (∗; C,D). Reproduced with permission from Tanaka (2016).
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FIGURE 6 | Summary of radiological–pathological correlation in adult M. pneumoniae pneumonia. Reproduced with permission from Tanaka et al. (1997).
RADIOLOGICAL ASSESSMENT OF
M. pneumoniae PNEUMONIA
The most common radiographic findings consist of unilateral
or bilateral areas of air-space consolidation and ground-
glass opacities. However, the findings are variable and can
include reticular or nodular opacities. Associated features
include bronchial wall thickening and occasionally small pleural
effusion. CT shows more accurately the presence and extent of
centrilobular nodules, the lobular distribution of ground-glass
opacities and a small amount of pleural effusion not visible
on chest radiograph. Typical findings of adult M. pneumoniae
pneumonia on chest radiograph and CT are demonstrated in
Figure 4. The findings of bronchiolitis and lobular consolidation
seen in histopathological specimens were seldom apparent on
radiography but were commonly evident on CT. The most
FIGURE 7 | Computed tomography of centrilobular nodules
predominant pattern in two patients with M. pneumoniae pneumonia.
Reproduced with permission from Tanaka et al. (2004).
distinct abnormality seen on CT consisted of poorly defined
centrilobular nodules, suggesting bronchiolitis. A study using
high-resolution CT shows the most frequent chest radiologic
finding was air-space consolidation, seen in 86% of 28 patients,
and most commonly involving the lower lobe and nodular
opacities were detected in 14 patients (Reittner et al., 2000).
The areas of patchy air-space consolidation or ground-glass
attenuation frequently had a lobular distribution, a characteristic
pathological feature of bronchopneumonia. Although the most
common abnormalities were thickening of the axial interstitium
appearing bronchovascular bundles thickening on radiograph
and CT (Tanaka et al., 1985).
PATHOLOGICAL FINDINGS IN OPEN
LUNG BIOPSY
Mycoplasma pneumoniae organism selectively attaches airway
ciliated epithelial cells (Tanaka et al., 2014) and therefore the
pathological findings are usually limited to the airway walls
as far down as small airways; the respiratory bronchioles.
Histopathologically, M. pneumoniae pneumonia is characterized
by acute cellular bronchiolitis with edematous and ulcerative
lesions of bronchial walls and by peribronchial and perivascular
interstitial opacities containing lymphocytes, plasma cells, and
macrophages. The wall of bronchioles contains mononuclear
cell and macrophage with a centrilobular distribution. In cases
of severe pneumonia, diffuse alveolar damage with fibrinous
exudates and hyaline membrane formation (Rollins et al.,
1986; Izumikawa et al., 2014). Histopathological observation
of open lung biopsy specimens from middle aged woman
in recovery phase of M. pneumoniae pneumonia are showed
in Figure 5. Low-magnification photomicrographs of small
airways shows cellular bronchiolitis with thickening walls
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FIGURE 8 | Bronchiolitis obliterans following M. pneumoniae infection. (A) Chest X-ray showing normal. (B) 99mTc-MAA perfusion scan revealing slight
defect. (C) 81mKr-aerosol ventilation demonstrating prominent multiple defects throughout the lung field. Reproduced with permission from Tanaka (2016).
and exudates in the lumen. High-magnification of alveolar
area discloses intra-alveolar inflammatory-cell infiltration and
organizing pneumonia with granulation tissue filling alveolar
ducts.
Summary of pathological–radiological correlations and
frequency of three major CT findings in 91 cases of adult
M. pneumoniae pneumonia were shown in Figure 6. It was
reported that M. pneumoniae pneumonia in the recovery
phase showed predominantly centrilobular nodular patterns,
which disclosed immunological inflammation remaining in the
small airways (Tanaka et al., 1985). However, some patients
demonstrated centrilobular nodules in the early phase of the
pneumonia (Figure 7), which mimicking T-helper type 1
pulmonary host response in the mice model (Tanaka et al.,
1996a).
HOST CMI AND RADIOLOGICAL
PATTERN
The CMI of the host plays an important role in the development
of M. pneumoniae pneumonia. M. pneumoniae pneumonia
in patients with immunodeficiency syndrome had a rack of
radiological chest findings (Foy et al., 1973). On the other
hand, the radiographic appearance of M. pneumoniae pneumonia
in patients with sarcoidosis showed a bilateral reticulonodular
pattern (Putman et al., 1975). Ito et al. (1995) reported a
married couple who developed M. pneumoniae pneumonia at
the same time, and whose severity of pneumonia, radiological
findings and serum soluble IL-2 receptor levels were marked
different between wife and husband. The wife developed acute
respiratory failure with high serum levels of soluble IL-2 receptor,
on the other hand, the husband suffered from pneumonia with
a moderate elevation of soluble IL-2 receptor. The difference
may be reflected in the serum soluble IL-2 receptor levels,
a marker of T cell activation in vivo. Serum IL-18 levels in
patients with severe M. pneumoniae pneumonia were higher
than those in mild cases (Tanaka et al., 2002), which suggested
IL-18 and T-helper 1(Th1) cytokines may play a significant
role in developing pneumonia. And IL-18 levels of pleural
effusion in pediatric patients also elevated (Narita et al., 2000).
In human M. pneumoniae pneumonia, positive rate of purified
protein derivative (PPD) test in patients with nodular opacities
predominant pattern on CT (group N) was higher than that in
patients with air-space consolidation or ground-glass opacities
predominant pattern on CT (group C) in M. pneumoniae
pneumonia (Tanaka et al., 1996b). The PPD skin reaction;
tuberculin skin test, is used not only to confirm past infection
of Mycobacterium tuberculosis but also to determine the CMI
of the host. In other words, patients with nodular opacities
predominant on CT showed a more marked response to PPD
than those with air-space consolidation predominant pattern
on CT.
BRONCHIOLITIS OBLITERANS
FOLLOWING M. pneumoniae INFECTION
The presence of centrilobular nodules in a patchy distribution
is characteristic of infectious bronchiolitis, allowing distinction
from non-infectious causes of bronchiolitis, which usually
have a diffuse distribution throughout both lungs (Chan
et al., 1999; Ebnother et al., 2001). We experienced a woman
suffered M. pneumoniae infection. She complained dyspnea
2 months after the infection. Her chest radiograph and CT
revealed overinflation with no centriacinar nodules (Figure 8).
Her pulmonary function test revealed a vital capacity of
2469 ml, an forced effort in 1 s; FEV1 of 940 ml, and
FEV1/FVC ratio of 41%, a V50/V25 ratio of 2.01, and
a residual volume/total lung capacity ratio of 47%. 99mTc-
MAA perfusion scan revealed slight defect and 81mKr-aerosol
ventilation scan demonstrated prominent multiple defects,
suggesting bronchiolitis obliterans. Centrilobular nodule of
under 500 µm could not detected in high-resolution CT scan,
therefore pulmonary functions are useful technique for detecting
subtle small airway abnormality.
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